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Luria-Delbrück Estimation of Turnip Mosaic Virus Mutation Rate
In Vivo
Francisca de la Iglesia,a Fernando Martínez,a Julia Hillung,a José M. Cuevas,a Philip J. Gerrish,b José-Antonio Daròs,a
and Santiago F. Elenaa,c
Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas-UPV, València, Spaina; Center for Theoretical and Evolutionary
Immunology, University of New Mexico, Albuquerque, New Mexico, USAb; and The Santa Fe Institute, Santa Fe, New Mexico, USAc
A potential drawback of recent antiviral therapies based on the transgenic expression of artificial microRNAs is the ease with
which viruses may generate escape mutations. Using a variation of the classic Luria-Delbrück fluctuation assay, we estimated
that the spontaneous mutation rate in the artificial microRNA (amiR) target of a plant virus was ca. 6 105 per replication
event.
The rate of spontaneous mutation is a key parameter to under-stand the genetic structure of populations over time.Mutation
represents the primary source of genetic variation on which nat-
ural selection and genetic drift operate. Although the exact value
of mutation rate is important for several evolutionary theories,
accurate estimates are available only for a reduced number of or-
ganisms (15). In the case of RNAviruses,mutation rates are orders
of magnitude higher than those of their DNA-based hosts (7).
These high mutation rates have important practical implications;
for instance, for the long-term durability of vaccination strategies
(6) and antiviral drugs (2), for the stability of live attenuated vac-
cines (26), for the eventual success of antiviral therapies based on
the concept of lethal mutagenesis (1), or to determine the risk of
new emerging viruses (14). The spontaneous mutation rate of a
virus can be evaluated in vivo using a variety of experimental ap-
proaches. Among the most commonly used approaches are (i)
estimating the frequency of mutants contained in a population
generated from a single clone (7, 23), (ii) counting the number of
mutant alleles accumulated in a locus which was protected against
the action of purifying selection (20, 25), (iii) counting the num-
ber of lethal alleles present in a population (10), (iv) estimating the
mean and variance in fitness declines among independent lineages
during a mutation accumulation experiment and then applying
the Mukai-Bateman method (8), or (v) using a fluctuation assay
(19). Among all of these approaches, the last is considered the
most flexible, robust, and reliable method (9). The fluctuation
test, originally developed by Luria and Delbrück (19), allows esti-
mation of the rate at which mutations arise in a genetic locus
associated with an easy-to-score phenotype. The estimates ob-
tained are independent of generation time and replication mode,
factors that are not available for most RNA viruses. Advanced
mathematical tools for the analysis of the distribution of the num-
ber of mutants across replicated cultures (the so-called Luria-
Delbrück distribution) are readily available and easy to adapt to
each experimental design (9).
The transgenic expression of 21-nucleotide (nt)-long artificial
microRNAs (amiR) complementary to viral genomes has been
proposed as a new antiviral strategy. Niu et al. (22) used the pre-
miRNA159a precursor to engineer an amiR containing a sequence
complementary to the RNA genome of Turnip mosaic potyvirus
(TuMV). Transgenic expression of this amiR in Arabidopsis thali-
ana conferred high levels of specific resistance. Similarly, a gene-
silencingmechanism (RNA interference [RNAi]) has been used in
in vitro assays as antiviral therapeutics to inhibit the replication of
several human viruses (5, 11, 16). However, a major issue of these
amiR-based antiviral therapies has been the emergence of escape
mutant viruses (3, 13, 17). These escape variants differ from the
wild-type virus by at least one point mutation in the 21-nt target,
leading to imperfect matching with the amiR. To evaluate the
durability of amiR-mediated resistance in plants, Lafforgue et al.
(17) performed an evolution experiment in which multiple inde-
pendent lineages of TuMV were founded with an ancestral virus
clone and allowed to evolve and diversify by serial passages in two
different hosts. The first host was a wild-type A. thaliana and the
second one was the partially resistant 10-4 transgenic A. thaliana
line that expressed amiR at subinhibitory concentrations. Period-
ically, the evolving populations were used to challenge the resis-
tance of the 12-4 transgenic A. thaliana line, which was fully resis-
tant to the ancestral virus. It was found that all lineages that
evolved in wild-type plants accumulated mutations in the amiR
target and acquired the capacity to successfully infect 12-4 plants
(17). The median time for lineages evolved in wild-type plants to
break resistance was 14 passages, while lineages evolved in par-
tially resistant plants only took 2 passages. The ease to break this
resistance correlated with the existence of natural variation for the
21-nt target sequence (A. Lafforgue, S. F. Elena, unpublished re-
sults), suggesting that this genomic region shall not be under
strong purifying selection.
The frequency at which mutations may be produced in the
amiR target locus in evolving TuMV populations is fundamental
to understanding the observed dynamics of resistance breaking.
Here, we report the results of a fluctuation assay experiment de-
signed to evaluate the spontaneous mutation rate at the amiR
target locus of TuMV. In this case, the phenotype associated with
the mutants was the ability to replicate in the 12-4 transgenic
plants expressing the antiviral amiR. We used a modification of
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the analytical method proposed in reference 12 that provides im-
proved accuracy and is especially well suited to large populations
and/or highmutation rates. This method is a generalization of the
statistical modeling developed by Lea and Coulson (18).
Figure 1 shows a scheme of the experimental design for this
fluctuation assay. A large stock of infectious sap was obtained
from Nicotiana benthamiana plants inoculated with a plasmid
containing TuMV cDNA (4, 17). This amplification step was nec-
essary to overcome the low-efficiency-infecting A. thaliana plants
with the TuMV cDNA. Sap was obtained by grinding infected
tissues in a mortar with liquid N2 and 20 volumes of extraction
buffer (50 mM potassium phosphate, pH 7.0, 3% polyethylene
glycol 6000). One hundred wild-type A. thaliana plants were in-
oculated with 5 l sap containing 10% carborundum applied on
three different leaves and gentle rubbing with a cotton swab (Fig.
1). After inoculation, plantsweremaintained in a growth chamber
(16 h of light at 25°C and 8 h of dark at 24°C). TuMV replicated
and systemically colonized the plants until reaching a population
size ofNi, where the subscript denotes the ith plant. From each of
these plants, virus was extracted from symptomatic tissue 14 days
postinoculation (dpi), as described above. Heterogeneity in virus
accumulation on leafs of different ages was minimized by pooling
them into a single extraction. However, as only a fraction of the
virus-infected host tissues was extracted, only a fraction (d) of
total virus produced was obtained and successfully transmitted.
This extract was divided into 10 parts, each of which was used to
inoculate a 12-4-resistant plant as described above; i.e., there were
10 resistant plants per each susceptible one (Fig. 1). Fourteen dpi,
the number of resistant plants on which infection was successfully
established was recorded. From this vector of counts, R, a muta-
tion rate was estimated using the following procedure. The num-
ber of mutants after growth and extraction from wild-type plants
has a distribution whose probability generating function is (12):
h(z)  (p  pz)
p pz
1 p pzNi
where p d/10 is the total dilution factor (dilution due to extrac-
tion, d, and dilution due to partitioning the extract into 10 parts),
 is mutation rate per amiR target locus, and z denotes the argu-
ment of the generating function h(·).
Infection is not a deterministic process, and a single virion has
probability q of infecting a plant and 1 q of not doing so. If the
diluted inoculum containsmmutants, then the probability of not
establishing an infection on the 12-4 resistant plants is (1  q)m.
The number of mutants is unknown and so is treated as a random
variable, and the total probability of not establishing an infection
is therefore m 0
 (1  q)m (m), where (m) is the mth coeffi-
cient in the expansion of h(z). The total probability of not estab-
lishing infection is therefore h(1  q). Since the probability of
establishing an infection is 50% when 1  1  q0.5  1⁄2,
where 0.5 is themedian infectious dose, the parameter qmay thus
be calculated as q  1  21⁄0.5.
The log-likelihood function for  is thus l(|R, Ni, d, 0.5) 
i 1
1000 log	i, where 100  10  1,000 is the total number of re-
sistant plants used in the fluctuation assay and
	(i)   h(1  q) if the ith plant is not infected1  h1  q if the ith plant is infected
This function is maximized at   ˆ, the maximum likelihood
(ML) estimate of the mutation rate. Therefore, in addition to the
vectorRwith the counts of infected 12-4 plants for each wild-type
plant, the other relevant parameters to be experimentally deter-
mined are Ni (i 1, . . ., 100), d, and 0.5.
First, the concentration of the TuMV genomic [TuMV()]
RNA strand in the original stock as well as resulting from each of
the 100 wild-type A. thaliana plants (e.g., Ni) was measured by
absolute reverse transcription (RT)-quantitative PCR (qPCR) us-
ing an external standard as described in reference 21. In short, the
standard curve was constructed using 1/5-fold dilution intervals
of TuMV() RNA in the range of 1.28  108 to 4  104 mole-
cules. Aliquots of 100 ng total RNA were reverse transcribed in
triplicate in the presence of 250 nM primer PI (5=-TAACCCCTT
AACGCCAAGTAAG-3=; sequence complementary to TuMV
GenBank accession no. AF530055.2, positions 9599 to 9620) with
Moloney murine leukemia virus (M-MuLV) reverse transcriptase
(Fermentas) in 20-l reactionmixtures for 10min at 25°C, 45min
at 42°C, and 5min at 50°C. Reactionswere stopped by heating the
mixtures at 72°C for 15 min. Sequence-specific qPCR analyses
were performed with 2 l reverse transcription products in 20
l final volume using the Maxima SYBR green master mix
reagent (Fermentas) and primers PI and PII (5=-CAATACGTG
CGAGAGAAGCACAC-3=; sequence homologous to TuMV posi-
tions 9448 to 9470) at 95°C for 10min, followed by 40 cycles of 15
s at 95°C and 1 min at 60°C. Considering the total aerial plant
masses (see below), measured Ni values ranged from 3.845 
1010 to 3.429  1011, with an average value of 1.226  1011
TuMV() RNA molecules per plant (95% confidence interval
[95% CI] around the mean, 1.110  1011 to 1.341  1011).
Second, the dilution factor d was approximated as the fraction
of wild-type plant tissue used to generate the sap that was later
used to inoculate the corresponding set of 12-4 resistant plants.
On average, the aerial part of the infected wild-type plants
weighted 0.922  0.090 g (1 the standard error of the mean
FIG 1 Schematic representation of the fluctuation assay. A TuMV stock was
produced from infected N. benthamiana plants that were previously inocu-
lated with a TuMV clone. This stock was used to mechanically inoculate 100
wild-type A. thaliana plants (phase 1). During this phase, erroneous viral rep-
lication produces spontaneousmutants in the amiR 21-nt target that accumu-
late in the population. Fourteen dpi, virus was purified from each of these
plants and used to inoculate batches of 10 A. thaliana 12-4 plants expressing
the antiviral amiR (phase 2). During this phase, only those genomes carrying a
mutation in the 21-nt target would eventually escape from the RNA silencing.
Plants inoculated with these mutants will develop symptoms, whereas plants
inoculated with the wild-type TuMV will not. The number of infected 12-4
plants showing symptoms of infection was recorded 14 dpi (red pots).
Mutation Rate in TuMV
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[SEM]) and the averageweight of the tissue ground to produce the
100 inocula was 0.122 0.007 g, which corresponds to a dilution
factor of d 0.132 0.021.
Third, a dose infectivity assay was used to evaluate 0.5. To do
so, the original TuMV stock was serially diluted with 1/5-fold
intervals in the range of 1/1 to 1/500, and each dilutionwas used to
inoculate sets of 10 plants. Twenty dpi, the number of symptom-
atic plants was recorded. Infectivity datawere subjected to a probit
analysis that rendered an estimate of themedian infectious dose of
0.5  8.826  10
6 TuMV genomes per 12-4 plant (95% CI,
4.543  106 to 1.779  107; goodness of fit test, 
2  2.694; 5
degrees of freedom [d.f.]; P 0.747).
Finally, the fluctuation assay rendered the following results.
From a total of 100 wild-typeA. thaliana plants used as a source of
TuMV inocula, only 11 contained escape mutants that produced
at least one 12-4 plant infected (five cases of 1/10 and two cases
each of 2/10, 3/10, and 5/10). Feeding all data into the ML algo-
rithm, the estimate of the mutation rate for the amiR target locus
was ˆ 5.545 105 mutations per replication event (95% CI,
2.886 105 to 9.507 105). Since the amiR target is 21-nt long,
this estimate can be expressed in a more common per-nucleotide
scale as 2.640  106 substitutions per site and per replication
event (s/n/r) (95% CI, 1.374  106 to 4.527  106). This em-
pirical estimate is between 17 to 30 times lower than the value
suggested by the simulations performed by Lafforgue et al. (17)
which, given the many assumptions behind the simulations, can
be considered a reasonable discrepancy.
Direct estimates of mutation rates for plant RNA viruses are
scarcer than for their animal and bacterial counterparts. The first
estimate ever reported for a plant virus was for Tobacco mosaic
virus and it was ca. 1.8 105 s/n/r (20). Later on, the mutation
rate for Tobacco etch virus (TEV) was estimated to range between
2.960  105 (23) and 4.754  106 s/n/r (25). Our data for
TuMV are in good agreement with those reported for TEV, an-
other potyvirus. Furthermore, all these estimates are well within
the range of 106 to 104 that was recently reported for several
animal RNA viruses and bacteriophages (24). Altogether, the re-
cent estimates obtained for plant RNA viruses and the reanalysis
made of previous data (24) suggest that the mutation rate of RNA
viruses may be lower than previously proposed (7).
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